Report top-line results from the Phase 3 TRYbeCA-1 trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 15 Jan 2021
- Due
- 31 Dec 2021
- Delivered
- 25 Oct 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“anticipate top-line results from the Phase 3 TRYbeCA-1 trial in second-line pancreatic cancer in 2021.”
What we found
Evidence strength A What the grades mean
The company reported the top-line results of the Phase 3 TRYbeCA-1 trial on October 25, 2021, which was within the 2021 deadline.
-
A Erytech Pharma S.A. 20-F filed 2022-04-27
“on October 25, 2021, we reported top-line final results of our Phase 3 clinical trial of eryaspase for the treatment of second-line advanced pancreatic cancer patients, which we refer to as the TRYbeCA-1 trial.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout late
- Indicative materiality
- High rules
- Action
- Report
- Deliverable
- Phase 3 TRYbeCA-1 trial top-line results
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Erytech Pharma S.A.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C624422-022138 · Corrections policy